Search results for "Vaccinations"
Chapter advocacy key to advancing ACP's priorities
ACP's legislative staff are following four key court cases on affirmative action, gun violence, climate change, and women's reproductive health care rights.
https://immattersacp.org/archives/2022/06/chapter-advocacy-key-to-advancing-acps-priorities.htm
1 Jun 2022
Studies examine persistent symptoms of COVID-19
A U.K. study found that COVID-19 vaccination after infection may help persistent symptoms, while a U.S. study found that the burden of such symptoms appears high.
https://immattersacp.org/weekly/archives/2022/05/24/5.htm
24 May 2022
MKSAP Quiz: Evaluation for influenza immunization
A 49-year-old man is evaluated for influenza immunization. Two weeks ago, he underwent surgical resection for stage III colon cancer. He will begin a 3-month course of adjuvant chemotherapy in 3 weeks. What is the preferred influenza immunization strategy?
https://immattersacp.org/weekly/archives/2022/05/24/3.htm
24 May 2022
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2022/05/latest-updates-on-acps-priorities-initiatives.htm
1 May 2022
Perioperative medicine changed in the pandemic
In the face of a lack of guidance on perioperative medicine during the COVID-19 pandemic, many hospitals are developing their own guidelines on timing of surgery after infection in vaccinated patients.
https://immattersacp.org/archives/2022/05/perioperative-medicine-changed-in-the-pandemic.htm
1 May 2022
Higher risk for DVT, PE, bleeding seen after COVID-19; long-term risk for VTE recurrence may be low
A Swedish study found that patients who had COVID-19 were at higher risk for a first deep venous thrombosis (DVT) for up to three months, pulmonary embolism (PE) for up to six months, and bleeding for up to two months, while a single-center study from France found that risk for venous thromboembolism (VTE) recurrence up to a year after COVID-19 was low.
https://immattersacp.org/weekly/archives/2022/04/12/2.htm
12 Apr 2022
Hepatitis B vaccine now recommended for adults ages 19 through 59 years
The Advisory Committee on Immunization Practices has changed its guidance to encourage clinicians to offer the vaccine to adult patients, rather than target those with risk factors or wait for it to be requested.
https://immattersacp.org/weekly/archives/2022/04/05/1.htm
5 Apr 2022
Latest pandemic research looks at persistent symptoms of COVID-19, rise in alcohol deaths
More than half of patients with mild COVID-19 reported symptoms months later in one study, while another found psychiatric and neurologic consequences were similar in ICU survivors with and without COVID-19. Other research looked at the rise in alcohol-related deaths and the safety of vaccination during pregnancy.
https://immattersacp.org/weekly/archives/2022/03/29/4.htm
29 Mar 2022
Fourth doses, stealth variant, rapid tests focus of latest COVID-19 research
A fourth vaccine dose increased antibodies but didn't significantly reduce infections in an Israeli study. Antibody response is similar with the stealth variant and with the original omicron variant, a small study showed. Other research found that a rapid antigen test caught most omicron infections, and the vaccines weren't associated with neurological conditions.
https://immattersacp.org/weekly/archives/2022/03/22/4.htm
22 Mar 2022
Two studies show effectiveness of mRNA boosters against omicron variant
Other recent research on COVID-19 revealed the high transmissibility of the omicron stealth variant and changes in the brain after SARS-CoV-2 infection.
https://immattersacp.org/weekly/archives/2022/03/15/5.htm
15 Mar 2022